ProMIS Neurosciences Inc. cotiza a 8.66 USD y tiene una capitalización bursátil de $78M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and …
| Periodo | 2026-11 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | — | $-30.05 | $-8.40 | $-9.98 |
| Estimado | — | $-6.71 | $-9.99 | $-6.04 |
| Sorpresa | — | -347.8% | +15.9% | -65.2% |
| Métrica | PMN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -432.6% | -32.0% | -400.6% |
| Current Ratio | 0.88 | 2.84 | -1.96 |
| Debt / Equity | — | 0.28 | — |